FDA Asks Endo to Remove Opioid Opana ER From Market

Hot legal news! The Food and Drug Administration issued a request to pharmaceutical manufacturer Endo to remove their opioid Opana ER from the market amid growing concern of the opioid crisis. While this request is just that, only a request, the FDA is hopeful Endo will comply, though Endo’s shareholders might need…… FindLaw News – Top Stories http://ift.tt/2teqwZD

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s